Immunotherapy Prescribing Patterns and Immune-Related Adverse Events in Patients With Head and Neck Cancer
{{output}}
Importance: Immunotherapy is approved for first-line treatment of recurrent/metastatic head and neck cancer (HNC). The prescribing patterns are largely unreported, and assessment of immune-related adverse events (irAEs) in patien... ...
